Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 93   

Articles published

ATOS 0.870 +0.040 (4.81%)
price chart
Atossa Genetics Inc. to Present at the Rodman & Renshaw 17th Annual Global ...
Company Contacts: Steven C. Quay, M.D., Ph.D. Chief Executive Officer & President Atossa Genetics Inc. Phone: (800) 351-3902 and Kyle Guse Chief Financial Officer, General Counsel and Secretary Atossa Genetics Inc. Phone: (800) 351-3902 Investor ...
Atossa Genetics, Inc. Announces Appointment of Scott Youmans as Chief ...
Company Contacts: Steven C. Quay, M.D., Ph.D. President & Chief Executive Officer Atossa Genetics Inc. Phone: (800) 351-3902 and Kyle Guse Chief Financial Officer, General Counsel and Secretary Atossa Genetics Inc. Phone: (800) 351-3902 Investor ...
Atossa Genetics, Inc. Announces Appointment of Scott Youmans as Chief ...  CNNMoney
Company Shares of Atossa Genetics Inc. (NASDAQ:ATOS) Drops by -9.06%
Atossa Genetics Inc. (NASDAQ:ATOS) has lost 9.06% during the past week and dropped 24.22% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 9.88%.
Atossa Genetics (ATOS) Stock Declines Today on Heavy Trading Volume
"We rate ATOSSA GENETICS INC (ATOS) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the ...
Related articles »  
Shares of Atossa Genetics Inc. (NASDAQ:ATOS) Drops by -0.98%
Atossa Genetics Inc. (NASDAQ:ATOS) has lost 0.98% during the past week and dropped 10.62% in the last 4 weeks. The shares have outperformed the S&P 500 by 0.27% in the past week but underperformed the index by 10.66% in the last 4 weeks.
Investors Watch List: Oncothyreon Inc (NASDAQ:ONTY), Atossa Genetics, Inc ...  Stock Transcript
Short Interest Update of Atossa Genetics Inc. (NASDAQ:ATOS)
Atossa Genetics Inc. (NASDAQ:ATOS) has shown a rise of 15.4% or 99,562 shares in the short positions. The bets have increased to 744,637 shares on June 30,2015 from 645,075 shares on June 15,2015.
Atossa Genetics Inc. (NASDAQ:ATOS) Price Target Update
Atossa Genetics Inc. (NASDAQ:ATOS): According to 2 Analysts, The short term target price has been estimated at $ 7.25.The target price could deviate by a maximum of $3.18 from the forecast price.
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
As a result the company improperly marketed its devices by using certain promotional claims to market the product not supported by the FDA.
Atossa Genetics Soars On Distribution Pact With Henry Schein  Benzinga
Atossa Genetics (ATOS) Gains; Henry Schein to Offer FullCYTE Breast Aspirator  StreetInsider.com
Atossa Genetics, Inc. (NASDAQ:ATOS) Has Huge Plans to Reverse the Downtrend
Atossa Genetics, Inc. (NASDAQ:ATOS, ATOS message board) stock broke the trading range on Monday as the company' recent press release announcing a new license agreement caught the attention of traders.
Atossa Genetics secures global license to Afimoxifene Gel (ATOS)  Seeking Alpha
Atossa Genetics Acquires Rights to Clinical Stage Proprietary Afimoxifene ...  MarketWatch
Atossa Genetics Inc (ATOS) Files Form 4 Insider Buying : H. Lawrence Remmel ...
Atossa Genetics Inc (ATOS): H. Lawrence Remmel , director of Atossa Genetics Inc purchased 5,400 shares on Jun 12, 2015.